Eculizumab Receives FDA Approval for Neuromyelitis Optica Spectrum Disorder

… study that were associated with eculizumab were upper respiratory tract infection (29%), nasopharyngitis (21%), diarrhea (16%), back pain (15%), …
Source: back pain